Tech Company Financing Transactions

Blaze Bioscience Funding Round

Blaze Bioscience closed a $9 million Series B financing round on 12/3/2013. Backers included private investors.

Transaction Overview

Company Name
Announced On
12/3/2013
Transaction Type
Venture Equity
Amount
$9,000,000
Round
Series B
Investors
Proceeds Purpose
The funds will be used to support the clinical development of Blaze's first Tumor PaintTM product candidate, BLZ-100, which is designed to assist surgeons in surgical excision of solid tumors by illuminating cancer cells intra-operatively in real time and at high resolution. A Phase 1 clinical trial of BLZ-100 will be initiated shortly. In addition, the company will use proceeds to support development of Optide drug candidates as part of the collaboration and option agreement entered into with Fred Hutchinson Cancer Research Center in June of this year.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
530 Fairview Ave. North 1400
Seattle, WA 98109
USA
Email Address
Overview
Blaze has taken on this inspiration as we meet the challenge of moving quickly to advance our first Tumor Paint product candidate, BLZ-100, through clinical trials and onto the market where we believe it will eventually help millions of cancer patients.
Profile
Blaze Bioscience LinkedIn Company Profile
Social Media
Blaze Bioscience Company Twitter Account
Company News
Blaze Bioscience News
Facebook
Blaze Bioscience on Facebook
YouTube
Blaze Bioscience on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Heather Franklin
  Heather Franklin LinkedIn Profile  Heather Franklin Twitter Account  Heather Franklin News  Heather Franklin on Facebook
VP - Bus. Development
Dennis Miller
  Dennis Miller LinkedIn Profile  Dennis Miller Twitter Account  Dennis Miller News  Dennis Miller on Facebook
VP - Finance
Mila Lobanova
  Mila Lobanova LinkedIn Profile  Mila Lobanova Twitter Account  Mila Lobanova News  Mila Lobanova on Facebook
VP - Manufacturing
Claudia Jochheim
  Claudia Jochheim LinkedIn Profile  Claudia Jochheim Twitter Account  Claudia Jochheim News  Claudia Jochheim on Facebook
VP - Operations
Laura Ishak
  Laura Ishak LinkedIn Profile  Laura Ishak Twitter Account  Laura Ishak News  Laura Ishak on Facebook
VP - R & D
Julia Novak
  Julia Novak LinkedIn Profile  Julia Novak Twitter Account  Julia Novak News  Julia Novak on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/2/2013: Fluential venture capital transaction
Next: 12/3/2013: XLumena venture capital transaction

 

Share this article

 


About Database of VC Transactions

Our team works diligently to document funding rounds that are announced publicly. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary